We have examined different approaches to segmenting the fibroglandular tissue in breast MRI when calculating quantitative background parenchymal enhancement (BPE) as a potential predictor of response to neoadjuvant treatment (pCR). Our results suggest that quantitative approaches to measure BPE might be preferable to visual BI-RADS as a biomarker of response. Change in quantitative BPE with treatment was associated with pCR; but pre-treatment BPE was not. Further research may be directed towards handling wrongful inclusion of non-parenchymal voxels.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords